# STOCKHOLM 1.0
#=GF ID   IMD
#=GF AC   PF08397.15
#=GF DE   IRSp53/MIM homology domain
#=GF AU   Wuster A;0000-0003-4162-5931
#=GF SE   Pfam-B_4120 (release 18.0)
#=GF GA   26.20 26.20;
#=GF TC   26.20 26.20;
#=GF NC   26.10 26.10;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -E 1000 -Z 75585367 --cpu 4 HMM pfamseq
#=GF TP   Family
#=GF WK   IMD_domain
#=GF CL   CL0145
#=GF RN   [1]
#=GF RM   14752106
#=GF RT   A novel actin bundling/filopodium-forming domain conserved in
#=GF RT   insulin receptor tyrosine kinase substrate p53 and missing in
#=GF RT   metastasis protein. 
#=GF RA   Yamagishi A, Masuda M, Ohki T, Onishi H, Mochizuki N; 
#=GF RL   J Biol Chem 2004;279:14929-14936.
#=GF DR   INTERPRO; IPR013606;
#=GF DR   SO; 0100021; polypeptide_conserved_region;
#=GF CC   The N-terminal predicted helical stretch of the insulin receptor
#=GF CC   tyrosine kinase substrate p53 (IRSp53) is an evolutionary
#=GF CC   conserved F-actin bundling domain involved in filopodium
#=GF CC   formation. The domain has been named IMD after the IRSp53 and
#=GF CC   missing in metastasis (MIM) proteins in which it occurs.
#=GF CC   Filopodium-inducing IMD activity is regulated by Cdc42 and Rac1
#=GF CC   and is SH3-independent [1].
#=GF SQ   4
#=GS MTSS1_HUMAN/16-237  AC O43312.2
#=GS MTSS2_HUMAN/15-239  AC Q765P7.1
#=GS BAIP2_HUMAN/17-237  AC Q9UQB8.1
#=GS BI2L2_HUMAN/16-226  AC Q6UXY1.1
MTSS1_HUMAN/16-237             FQTIISDMKGSYPVWEDFINKAGKLQSQLRTTVVAAAAFLDAFQKVADMATNTRGGTREIGSALTRMCMRHRSIEAKLRQFSSALIDCLINPLQEQMEEWKKVANQLDKDHAKEYKKARQEIKKKSSDTLKLQKKAKK...GRGDIQPQLDSA..LQDVNDKYLLLEETEKQAVRKALIEERGRFCTFISMLRPVIEEEISMLGE.ITHLQTISEDLKSLTMDPHKLP
MTSS2_HUMAN/15-239             FQAIVNDMKSSYPIWEDFNSKATKLHSQLRTTVLAAVAFLDAFQKVADMATNTRGATRDIGSALTRMCMRHRSIETKLRQFTNALLESLINPLQERIEDWKKAANQLDKDHAKEYKRARHEIKKKSSDTLKLQKKARKELLGKGDLQPQLDSA..LQDVNDMYLLLEETEKQAVRRALIEERGRFCTFITFLQPVVNGELTMLGE.ITHLQGIIDDLVVLTAEPHKLP
BAIP2_HUMAN/17-237             YKTIMEQFN...PSLRNFIAMGKNYEKALAGVTYAAKGYFDALVKMGELASESQG.SKELGDVLFQMAEVHRQIQNQLEEMLKSFHNELLTQLEQKVELDSRYLSAALKKYQTEQRSKGDALDKCQAELKKLRKKSQG...SKNPQKYSDKELQYIDAISNKQGELENYVSDGYKTALTEERRRFCFLVEKQCAVAKNSAAYHSKGKELLAQKLPLWQQACADPSKIP
BI2L2_HUMAN/16-226             YKSIMEQFN...PALENLVYLGNNYLRAFHALSEAAEVYFSAIQKIGERALQSPT.SQILGEILVQMSDTQRHLNSDLEVVVQTFHGGLLQHMEKNTKLDMQFIKDSRQHYELEYRHRAANLEKCMSELWRMERKRDK..........NVREM..KESVNRLHAQMQAFVSESQRAAELEEKRRYRFLAEKHLLLSNTFLQFFGRARGMLQNRVLLWKEQ.SEASRSP
#=GC seq_cons                  apoIhpphp...PshEsFlshusphpptL+ssshAAtuahDAhQKlu-hAopopG.o+-lGssLspMs.pHRpIpscLcphspuhhssLls.LpcphE..p+hhsphcKcatpEY++ttpplcKppS-hhKLpKKucK...u+ss.p.plcph..lpsVNchah.LEph.ppuhRpALlEERtRFChhlphhpsVspsplshhGc.hshLQshl..hpphsu-PpKlP
